Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings

Congenital myasthenic syndromes (CMS) are inherited disorders that lead to abnormal neuromuscular transmission. Post-synaptic mutations are the main cause of CMS, particularly mutations in CHRNE. We report a novel homozygous CHRNE pathogenic variant in two Egyptian siblings showing a CMS. Interestin...

Full description

Bibliographic Details
Main Authors: Marta Gómez-García de la Banda, Emmanuel Simental-Aldaba, Nagia Fahmy, Damien Sternberg, Patricia Blondy, Susana Quijano-Roy, Edoardo Malfatti
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.909715/full
_version_ 1818264663086858240
author Marta Gómez-García de la Banda
Marta Gómez-García de la Banda
Marta Gómez-García de la Banda
Emmanuel Simental-Aldaba
Emmanuel Simental-Aldaba
Nagia Fahmy
Damien Sternberg
Damien Sternberg
Patricia Blondy
Susana Quijano-Roy
Susana Quijano-Roy
Susana Quijano-Roy
Susana Quijano-Roy
Edoardo Malfatti
Edoardo Malfatti
Edoardo Malfatti
Edoardo Malfatti
author_facet Marta Gómez-García de la Banda
Marta Gómez-García de la Banda
Marta Gómez-García de la Banda
Emmanuel Simental-Aldaba
Emmanuel Simental-Aldaba
Nagia Fahmy
Damien Sternberg
Damien Sternberg
Patricia Blondy
Susana Quijano-Roy
Susana Quijano-Roy
Susana Quijano-Roy
Susana Quijano-Roy
Edoardo Malfatti
Edoardo Malfatti
Edoardo Malfatti
Edoardo Malfatti
author_sort Marta Gómez-García de la Banda
collection DOAJ
description Congenital myasthenic syndromes (CMS) are inherited disorders that lead to abnormal neuromuscular transmission. Post-synaptic mutations are the main cause of CMS, particularly mutations in CHRNE. We report a novel homozygous CHRNE pathogenic variant in two Egyptian siblings showing a CMS. Interestingly, they showed different degrees of extraocular and skeletal muscle involvement; both presented only a partial response to cholinesterase inhibitors, and rapidly and substantially ameliorated after the addition of oral β2 adrenergic agonists. Here, we enlarge the genetic spectrum of CHRNE-related congenital myasthenic syndromes and highlight the importance of a β2 adrenergic agonists treatment.
first_indexed 2024-12-12T19:38:29Z
format Article
id doaj.art-2d021aa9abe64deb8d77e3147c6f7f0a
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-12T19:38:29Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-2d021aa9abe64deb8d77e3147c6f7f0a2022-12-22T00:14:15ZengFrontiers Media S.A.Frontiers in Neurology1664-22952022-06-011310.3389/fneur.2022.909715909715Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian SiblingsMarta Gómez-García de la Banda0Marta Gómez-García de la Banda1Marta Gómez-García de la Banda2Emmanuel Simental-Aldaba3Emmanuel Simental-Aldaba4Nagia Fahmy5Damien Sternberg6Damien Sternberg7Patricia Blondy8Susana Quijano-Roy9Susana Quijano-Roy10Susana Quijano-Roy11Susana Quijano-Roy12Edoardo Malfatti13Edoardo Malfatti14Edoardo Malfatti15Edoardo Malfatti16Pediatric Neurology and ICU Department, AP-HP Université Paris Saclay, Hôpital Raymond Poincaré, Garches, FranceReference Center for Neuromuscular Diseases Centre “Nord- Est- Ile de France”, FILNEMUS, Creteil, FranceEuropean Reference Center Network (Euro-NMD ERN), Paris, FranceAPHP, Centre de Référence de Pathologie Neuromusculaire Nord-Est-Ile-de-France, Henri Mondor University Hospital, Créteil, FranceDepartment of Neurorehabilitation, Instituto Nacional de Rehabilitación “LGII”, Mexico City, MexicoNeuromuscular Unit, Faculty of Medicine, Ain Shams University, Cairo, EgyptEuropean Reference Center Network (Euro-NMD ERN), Paris, FranceService de Biochimie Métabolique, Centre de Génétique, Groupe Hospitalier Pitié-Salpêtrière, APHP Sorbonne Université, Paris, FranceEuropean Reference Center Network (Euro-NMD ERN), Paris, FrancePediatric Neurology and ICU Department, AP-HP Université Paris Saclay, Hôpital Raymond Poincaré, Garches, FranceReference Center for Neuromuscular Diseases Centre “Nord- Est- Ile de France”, FILNEMUS, Creteil, FranceEuropean Reference Center Network (Euro-NMD ERN), Paris, FranceCentre de Recherche en Myologie, UMRS974, Paris, FranceReference Center for Neuromuscular Diseases Centre “Nord- Est- Ile de France”, FILNEMUS, Creteil, FranceAPHP, Centre de Référence de Pathologie Neuromusculaire Nord-Est-Ile-de-France, Henri Mondor University Hospital, Créteil, FranceUniv Paris Est Créteil, INSERM, IMRB, Créteil, France0AP-HP, Hôpital Mondor, Service d'histologie, Créteil, FranceCongenital myasthenic syndromes (CMS) are inherited disorders that lead to abnormal neuromuscular transmission. Post-synaptic mutations are the main cause of CMS, particularly mutations in CHRNE. We report a novel homozygous CHRNE pathogenic variant in two Egyptian siblings showing a CMS. Interestingly, they showed different degrees of extraocular and skeletal muscle involvement; both presented only a partial response to cholinesterase inhibitors, and rapidly and substantially ameliorated after the addition of oral β2 adrenergic agonists. Here, we enlarge the genetic spectrum of CHRNE-related congenital myasthenic syndromes and highlight the importance of a β2 adrenergic agonists treatment.https://www.frontiersin.org/articles/10.3389/fneur.2022.909715/fullcongenital myasthenic syndromeCHRNEneuromuscular junctionβ2 adrenergic agonistssalbutamol
spellingShingle Marta Gómez-García de la Banda
Marta Gómez-García de la Banda
Marta Gómez-García de la Banda
Emmanuel Simental-Aldaba
Emmanuel Simental-Aldaba
Nagia Fahmy
Damien Sternberg
Damien Sternberg
Patricia Blondy
Susana Quijano-Roy
Susana Quijano-Roy
Susana Quijano-Roy
Susana Quijano-Roy
Edoardo Malfatti
Edoardo Malfatti
Edoardo Malfatti
Edoardo Malfatti
Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings
Frontiers in Neurology
congenital myasthenic syndrome
CHRNE
neuromuscular junction
β2 adrenergic agonists
salbutamol
title Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings
title_full Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings
title_fullStr Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings
title_full_unstemmed Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings
title_short Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings
title_sort case report a novel achr epsilon variant causing a clinically discordant salbutamol responsive congenital myasthenic syndrome in two egyptian siblings
topic congenital myasthenic syndrome
CHRNE
neuromuscular junction
β2 adrenergic agonists
salbutamol
url https://www.frontiersin.org/articles/10.3389/fneur.2022.909715/full
work_keys_str_mv AT martagomezgarciadelabanda casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT martagomezgarciadelabanda casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT martagomezgarciadelabanda casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT emmanuelsimentalaldaba casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT emmanuelsimentalaldaba casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT nagiafahmy casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT damiensternberg casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT damiensternberg casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT patriciablondy casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT susanaquijanoroy casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT susanaquijanoroy casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT susanaquijanoroy casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT susanaquijanoroy casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT edoardomalfatti casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT edoardomalfatti casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT edoardomalfatti casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings
AT edoardomalfatti casereportanovelachrepsilonvariantcausingaclinicallydiscordantsalbutamolresponsivecongenitalmyasthenicsyndromeintwoegyptiansiblings